Assignee
IMMUNOVATIVE THERAPIES LTD
IL·21 granted patents·7 pending applications·257 citations·filing 2004–2019
Top patents by PatentIndex Score
28 records- 0198US7402431B2T-cell therapy formulationIMMUNOVATIVE THERAPIES LTD·Filed 2005·Granted Jul 22, 2008·78 cites·3 claims
- 0296US7678572B2Methods for preparing T-cells for cell therapyIMMUNOVATIVE THERAPIES LTD·Filed 2005·Granted Mar 16, 2010·28 cites·13 claims
- 0396US7435592B2Compositions for allogeneic cell therapyIMMUNOVATIVE THERAPIES LTD·Filed 2004·Granted Oct 14, 2008·50 cites·22 claims
- 0495US9511127B2Method to formulate T-cellsIMMUNOVATIVE THERAPIES LTD·Filed 2014·Granted Dec 6, 2016·8 cites·8 claims
- 0595US9352001B2Method for stimulating a host immune systemIMMUNOVATIVE THERAPIES LTD·Filed 2014·Granted May 31, 2016·8 cites·6 claims
- 0695US8012750B2T-cell activation deviceIMMUNOVATIVE THERAPIES LTD·Filed 2009·Granted Sep 6, 2011·21 cites·9 claims
- 0795US7592431B2Biodegradable T-cell Activation deviceIMMUNOVATIVE THERAPIES LTD·Filed 2006·Granted Sep 22, 2009·28 cites·10 claims
- 0894US7956164B2Device for enhancing immunostimulatory capabilities of T-cellsIMMUNOVATIVE THERAPIES LTD·Filed 2010·Granted Jun 7, 2011·10 cites·13 claims
- 0992US8354276B2T-cell compositions that elicit type I cytokine responseIMMUNOVATIVE THERAPIES LTD·Filed 2010·Granted Jan 15, 2013·5 cites·12 claims
- 1092US7943180B2Method for stimulating a host immune system by administering an allogeneic cell materialIMMUNOVATIVE THERAPIES LTD·Filed 2008·Granted May 17, 2011·7 cites·11 claims
- 1191US9593308B2Device for enhancing immunostimulatory capabilities of T-cellsIMMUNOVATIVE THERAPIES LTD·Filed 2014·Granted Mar 14, 2017·5 cites·8 claims
- 1289US7972594B2Ablative immunotherapyIMMUNOVATIVE THERAPIES LTD·Filed 2007·Granted Jul 5, 2011·8 cites·13 claims
- 1373US10751372B2Vaccine compositions and methodsIMMUNOVATIVE THERAPIES LTD·Filed 2018·Granted Aug 25, 2020·0 cites·6 claims
- 1473US10318712B2Automated device for biologic drug distributionIMMUNOVATIVE THERAPIES LTD·Filed 2016·Granted Jun 11, 2019·1 cites·4 claims
- 1571US11037087B2Automated device for biologic drug distributionIMMUNOVATIVE THERAPIES LTD·Filed 2019·Granted Jun 15, 2021·0 cites·16 claims
- 1670US10548956B2Allogeneic cellular immunotherapy for opportunistic infectionIMMUNOVATIVE THERAPIES LTD·Filed 2014·Granted Feb 4, 2020·0 cites·9 claims
- 1769US10744158B2Th1 vaccination priming for active immunotherapyIMMUNOVATIVE THERAPIES LTD·Filed 2017·Granted Aug 18, 2020·0 cites·5 claims
- 1869US10729754B2Treatment of human immunodeficiency virus/acquired immunodeficiency syndromeIMMUNOVATIVE THERAPIES LTD·Filed 2018·Granted Aug 4, 2020·0 cites·9 claims
- 1965US11045541B2Allogeneic T-cell compositions for induction of IL-12IMMUNOVATIVE THERAPIES LTD·Filed 2015·Granted Jun 29, 2021·0 cites·6 claims
- 2065US9320794B2Ablative immunotherapyIMMUNOVATIVE THERAPIES LTD·Filed 2013·Granted Apr 26, 2016·0 cites·6 claims
- 2162US10272143B2Treatment of human immunodeficiency virus/acquired immunodeficiency syndromeIMMUNOVATIVE THERAPIES LTD·Filed 2015·Granted Apr 30, 2019·0 cites·9 claims
- 2256US2014178334A1Methods and compositions for liquidation of tumorsIMMUNOVATIVE THERAPIES LTD·Filed 2014·Application pending·0 cites
- 2356US2016206718A1Compositions for Liquidation of TumorsIMMUNOVATIVE THERAPIES LTD·Filed 2016·Application pending·0 cites
- 2455US2016361404A1Methods and compositions for inhibition of Treg cellsIMMUNOVATIVE THERAPIES LTD·Filed 2016·Application pending·0 cites
- 2551US2011250173A1Methods and compositions for inhibition of Treg cellsIMMUNOVATIVE THERAPIES LTD·Filed 2011·Application pending·0 cites
- 2651US2016243231A1Ablative ImmunotherapyIMMUNOVATIVE THERAPIES LTD·Filed 2016·Application pending·0 cites
- 2750US2011142887A1Methods and compositions for liquidation of tumorsIMMUNOVATIVE THERAPIES LTD·Filed 2010·Application pending·0 cites
- 2849US2008112963A1Ablative immunotherapyIMMUNOVATIVE THERAPIES LTD·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMMUNOVATIVE THERAPIES LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →